Canton Strategic grants Sommers 53,763 stock options

Q: When do Jill E. Sommers’s CNTN options vest?

Of the 53,763 shares subject to the option, 26,881 were vested as of October 23, 2026; 13,441 shall vest on November 1, 2026, and the remaining 13,441 shall vest on February 1, 2027. Each future vesting is subject to continuous board service immediately before the applicable date.

Q: Under what policy did CNTN issue Jill E. Sommers’s option grant?

The option was issued under Canton Strategic Holdings’ Non-Employee Director Compensation Policy as an annual director equity grant.

The award has two future vesting dates, each contingent on continuous board service immediately before vesting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Canton Strategic Holdings, Inc. (CNTN) granted director Jill E. Sommers a direct option covering 53,763 common shares on October 23, 2026. The option has an exercise price of $1.86 per share and expires October 23, 2036. It was issued under the Non-Employee Director Compensation Policy as an annual director equity grant.

Of the shares subject to the option, 26,881 were vested as of October 23, 2026; 13,441 shall vest on November 1, 2026, and the remaining 13,441 shall vest on February 1, 2027. Each vesting date is subject to Sommers’s continuous service as a board member immediately before that date.

Insider Trade Summary

Grant/Award: 53,763 shares

Grant/Award 1 txn

Insider Sommers Jill E.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) ^{F2, F1}	53,763	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 53,763 contracts (Direct)

Footnotes (2)

F1. Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 26,881 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on November 1, 2026, and (iii) the remaining 13,441 shares shall vest on February 1, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.
F2. This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

Key Figures

Option grant: 53,763 options covering 53,763 common shares Exercise price: $1.86 per share Expiration date: October 23, 2036 +3 more

6 metrics

Option grant 53,763 options covering 53,763 common shares Direct grant to director Jill E. Sommers on October 23, 2026

Exercise price $1.86 per share Option grant to Jill E. Sommers

Expiration date October 23, 2036 Option grant to Jill E. Sommers

Shares vested 26,881 shares Vested as of October 23, 2026

Future vesting 13,441 shares Shall vest on November 1, 2026, subject to continuous board service immediately before vesting

Future vesting 13,441 shares Shall vest on February 1, 2027, subject to continuous board service immediately before vesting

Key Terms

Stock Option (Right to Buy), Amended and Restated 2023 Omnibus Equity Incentive Plan, Non-Employee Director Compensation Policy

3 terms

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

Amended and Restated 2023 Omnibus Equity Incentive Plan financial

"Amended and Restated 2023 Omnibus Equity Incentive Plan"

Non-Employee Director Compensation Policy financial

"Non-Employee Director Compensation Policy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did CNTN grant Jill E. Sommers, and what is the exercise price?

Canton Strategic Holdings granted director Jill E. Sommers an option covering 53,763 common shares at an exercise price of $1.86 per share on October 23, 2026.

When do Jill E. Sommers’s CNTN options vest?

Of the 53,763 shares subject to the option, 26,881 were vested as of October 23, 2026; 13,441 shall vest on November 1, 2026, and the remaining 13,441 shall vest on February 1, 2027. Each future vesting is subject to continuous board service immediately before the applicable date.

Under what policy did CNTN issue Jill E. Sommers’s option grant?

The option was issued under Canton Strategic Holdings’ Non-Employee Director Compensation Policy as an annual director equity grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/27/2026 - 06:34 PM EDT Accepted by SEC EDGAR 10/27/2026 - 06:33 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sommers Jill E.

(Last)

(First)

(Middle)

CANTON STRATEGIC HOLDINGS, INC

1460 BROADWAY

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Canton Strategic Holdings, Inc. [ CNTN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$1.86	10/23/2026		A		53,763		⁽¹⁾	10/23/2036	Common Stock	53,763	⁽²⁾	53,763	D

Explanation of Responses:

1. Grant of option to purchase Common Stock under the Issuer's Amended and Restated 2023 Omnibus Equity Incentive Plan. Of the shares subject to the option, (i) 26,881 shares were vested as of October 23, 2026, (ii) 13,441 shares shall vest on November 1, 2026, and (iii) the remaining 13,441 shares shall vest on February 1, 2027, in each case subject to the Reporting Person's continuous service as a member of the Issuer's board of directors immediately prior to the applicable vesting date.

2. This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant.

	/s/ Jill Sommers	10/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR